Retrospective analysis and patient satisfaction assessment of insulin pump therapy in patients with type 2 diabetes

Southern Medical Journal

Volumn 104, Issue 1, 2011, Pages 24-28

  Gentry, Chad K ^a   Cross, L Brian ^a   Gross, Benjamin N ^a   McFarland, M Shawn ^a   Bestermann, William H ^a  

^a Holston Medical Group   (United States)

Author keywords

continous subcutaneous insulin infusion (CSII); insulin pump therapy; patient satisfaction; pharmacist; type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTINOUS SUBCUTANEOUS INSULIN INFUSION; CROSS-SECTIONAL STUDY; DRUG DOSE REDUCTION; ELECTRONIC MEDICAL RECORD; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN INFUSION; INSULIN PUMP; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SATISFACTION; RETROSPECTIVE STUDY; WEIGHT CHANGE;

CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INFUSIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SATISFACTION; RETROSPECTIVE STUDIES;

EID: 78650864366     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3181fa7230     Document Type: Article

References (16)

1. Nielsen S, Kain D, Szudizik E, et al. Use of continuous subcutaneous insulin infusion pump in patients with type 2 diabetes mellitus. Diabetes Educ 2005;31:843-848.
2. Wittlin S. Treating the spectrum of type 2 diabetes: emphasis on insulin pump therapy. Diabetes Educ 2006;32:39S-46S.
3. Nathan DB, Buse JB, Davidson MB, et al; American Diabetes Association; European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care 2009;32:193-203.
4. Turner RC, Cull CA, Frighi V, et al. Glycemic control with diet, sulfo-nylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 1999;281:2005-2012.
5. Wainstein J, Metzger M, Wexler ID, et al. The use of continuous insulin delivery systems in severely insulin-resistant patients. Diabetes Care 2001;27:1299.
6. Heinemann L, Weyer C, Rauhaus M, et al. Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin as-part. Diabetes Care. 1998; 21: 1910-1914.
7. Lepore M, Pampanelli S, Fanelli C, et al. Pharmacokinetics and phar-macodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 2000;49:2142-2148.
8. Heise T, Tusek C, Bott S, et al. Investigating the drug accumulation of two premixed insulins. Diabetes 2003;52:A121.
9. Pickup J, Renard E. Long-acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes. Diabetes Care 2008;31(supp 2):S140-S145.
10. Raskin P, Bode BW, Marks JB, et al. Continuous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study. Diabetes Care 2003;26: 2598-2603.
11. Berthe E, Lireux B, Coffin C, et al. Effectiveness of intensive insulin therapy by multiple daily injections and continuous subcutaneous infusion: a comparison study in type 2 diabetes with conventional insulin regimen failure. Horm Metab Res 2007;39:224-229.
12. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: a meta analysis. Diabetes Care 2003;26:1079-1087.
13. U.K. prospective diabetes study 16. Overview of 6 years' of therapy of type II diabetes-a progressive disease. Diabetes 1995;44:1249-1258.
14. Monnier L, Lapinski H, Collette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HBA (1c). Diabetes Care 2003;26:881-885.
15. Pouwels MJ, Tack CJ, Hermus AR, et al. Treatment with intravenous insulin followed by continuous subcutaneous insulin infusion improves glycaemic control in severely resistant type 2 diabetic patients. Diabet Med 2003;20:76-79.
16. Wainstein J, Metzger M, Boaz M, et al. Insulin pump therapy vs. multiple daily injections in obese type 2 diabetic patients. Diabet Med 2005; 22:1037-1046.